Atlas Trials

Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality

Clinical trial NCT05895240 · UNKNOWN

Trial details

NCT number
NCT05895240
Sponsor
Jinnah Postgraduate Medical Centre
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Severe SepsisSeptic ShockMODS
Start date
2023-05-01
Primary completion
2023-10-01
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.